These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9750683)

  • 21. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts in electrical defibrillation.
    Truong JH; Rosen P
    J Emerg Med; 1997; 15(3):331-8. PubMed ID: 9258783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of semi-automatic defibrillators outside the hospital].
    Kacet S; Zghal N; Kouakam C; Benameur N; Goldstein P
    Arch Mal Coeur Vaiss; 2002 Oct; 95(10):945-9. PubMed ID: 12462906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic changes due to intraoperative testing of the automatic implantable cardioverter defibrillator: implications for anesthesia management.
    Keyl C; Tassani P; Kemkes B; Markewitz A; Hoffman E; Steinbeck G
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):442-7. PubMed ID: 8400100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct current application: easy induction of ventricular fibrillation for the determination of the defibrillation threshold in patients with implantable cardioverter defibrillators.
    Weismüller P; Richter P; Binner L; Grossmann G; Hemmer W; Höher M; Kochs M; Hombach V
    Pacing Clin Electrophysiol; 1992 Aug; 15(8):1137-43. PubMed ID: 1381081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of refractory ventricular fibrillation by combined internal (epicardial) and external (transthoracic) defibrillation.
    Fredman CS; Biermann KM; Barold SS; Dolan PH; Marbarger JP; Garrett TE
    Pacing Clin Electrophysiol; 1996 Jun; 19(6):1003-5. PubMed ID: 8774835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double Sequential External Defibrillation and Survival from Out-of-Hospital Cardiac Arrest: A Case Report.
    Johnston M; Cheskes S; Ross G; Verbeek PR
    Prehosp Emerg Care; 2016; 20(5):662-6. PubMed ID: 27077941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing should not be routinely performed at the time of implantable cardioverter defibrillator implantation.
    Healey JS; Brambatti M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):347-51. PubMed ID: 24736424
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of ventricular fibrillations with different characteristics in the local electrocardiogram: large and small amplitude of activation, and its implication for implantable cardioverter defibrillator treatment.
    Chinushi M; Washizuka T; Kasai H; Ohhira K; Satoh M; Aizawa Y
    Jpn Circ J; 1999 Dec; 63(12):1007-10. PubMed ID: 10614851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency simultaneous transthoracic and epicardial defibrillation for refractory ventricular fibrillation during routine implantable cardioverter-defibrillator testing in the operating room.
    Cohen TJ; Scheinman MM; Pullen BT; Coggins DL; Gonzalez RP; Epstein LM; Grogin HR; Griffin JC
    Am J Cardiol; 1993 Mar; 71(7):619-22. PubMed ID: 8438757
    [No Abstract]   [Full Text] [Related]  

  • 35. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.
    Russo AM; Chung MK
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423
    [No Abstract]   [Full Text] [Related]  

  • 36. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 37. A prospective, randomized evaluation of effect of ventricular fibrillation duration on defibrillation thresholds in humans.
    Bardy GH; Ivey TD; Allen M; Johnson G
    J Am Coll Cardiol; 1989 May; 13(6):1362-6. PubMed ID: 2703617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence rather than costs must guide use of the implantable cardioverter defibrillator.
    Delacretaz E; Schlaepfer J; Metzger J; Fromer M; Kappenberger L
    Am J Cardiol; 2000 Nov; 86(9A):52K-57K. PubMed ID: 11084101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.